Downloads

Here you will find documents relating to the prescription, the application to your health insurance provider (both of which apply only in Germany) and choosing the right device.

Claims for reimbursement

There is a separate form for each condition for which there is robust research evidence: Parkinson’s disease, stroke, motor neurone disease, multiple sclerosis and COPD. You do not need to put anything together — simply download the form, complete it on your computer or print it out, sign it and send it off. The scientific evidence is included as an attachment, and an information sheet for healthcare practices is enclosed.

Important: The application must be received by the health insurance provider before the purchase is made. Anyone who buys the item first and then submits the invoice will, as a rule, have no prospect of a refund, even if they are entitled to one.

Appeal against a rejection

It is common for an application to be rejected at the first attempt, and this does not mark the end of the process. You have one month from receipt of the decision; the appeal is informal and free of charge, and you do not need a solicitor. The most common reason given is that the device is not included in the list of assistive devices — but this argument alone does not hold water, as established case law holds that the list is not exhaustive.

Which device is suitable? MEP reference values for guidance

The EMST150 and the EMST75 lite differ in terms of their training range. Which device is suitable depends on the maximum expiratory pressure (MEP) — and this varies significantly according to age and gender. A value that indicates weakness in a 30-year-old may fall within the normal range for an 80-year-old.

This overview summarises the reference values by age and gender and shows which device is appropriate for each range. It is not a substitute for actual measurement: MEP is determined in a practice or clinic, and the choice is made by the treating doctor.

The MEP is also suitable as a parameter for monitoring progress — an increase during training is the simplest objective evidence that the treatment is working, and should therefore be included in all progress records and in any appeal.